Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Nuria Pedreño-Lopez"'
Autor:
Fangzhu Zhao, Zachary T. Berndsen, Nuria Pedreño-Lopez, Alison Burns, Joel D. Allen, Shawn Barman, Wen-Hsin Lee, Srirupa Chakraborty, Sandrasegaram Gnanakaran, Leigh M. Sewall, Gabriel Ozorowski, Oliver Limbo, Ge Song, Peter Yong, Sean Callaghan, Jessica Coppola, Kim L. Weisgrau, Jeffrey D. Lifson, Rebecca Nedellec, Thomas B. Voigt, Fernanda Laurino, Johan Louw, Brandon C. Rosen, Michael Ricciardi, Max Crispin, Ronald C. Desrosiers, Eva G. Rakasz, David I. Watkins, Raiees Andrabi, Andrew B. Ward, Dennis R. Burton, Devin Sok
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
SIVmac239 infection of macaques is a favored model of human HIV infection, but antibody-mediated protection for SIVmac239 is insufficiently understood. Here, Zhao and Berndsen et al isolated nAbs and confirmed protection against SIVmac239 infection i
Externí odkaz:
https://doaj.org/article/2aa7798e6f944e178232a7a70fe98e0c
Autor:
Ana Moyano, Oscar Blanch-Lombarte, Laura Tarancon-Diez, Nuria Pedreño-Lopez, Miguel Arenas, Tamara Alvaro, Concepción Casado, Isabel Olivares, Mar Vera, Carmen Rodriguez, Jorge del Romero, Cecilio López-Galíndez, Ezequiel Ruiz-Mateos, Julia G. Prado, María Pernas
Publikováno v:
Retrovirology, Vol 19, Iss 1, Pp 1-14 (2022)
Abstract Background Long-Term Non-Progressors (LTNPs) are untreated Human Immunodeficiency virus type 1 (HIV-1) infected individuals able to control disease progression for prolonged periods. However, the LTNPs status is temporary, as viral load incr
Externí odkaz:
https://doaj.org/article/9781fb5c03ed4e0cb8b67f8ba4137e88
Autor:
B.C. Rosen, M.J. Ricciardi, Nuria Pedreño-Lopez, T.B. Voigt, F.D. Laurino, J.J. Louw, A. Yrizarry-Medina, C. Panayiotou, T. Newbolt, K.L. Weisgrau, J.D. Lifson, R.C. Desrosiers, E.G. Rakasz, D.I. Watkins
Publikováno v:
Journal of Virus Eradication, Vol 8, Iss , Pp 100209- (2022)
Externí odkaz:
https://doaj.org/article/bde686e75fbc4ee58c7a298d70f40338
Autor:
Nuria Pedreño-Lopez, Michael J. Ricciardi, Brandon C. Rosen, Ge Song, Raiees Andrabi, Dennis R. Burton, Eva G. Rakasz, David I. Watkins
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 781-790 (2020)
Simian immunodeficiency virus (SIV) infection of Indian rhesus macaques (RMs) is one of the best-characterized animal models for human immunodeficiency virus (HIV) infection. Monoclonal antibodies (mAbs) have shown promise for prevention and treatmen
Externí odkaz:
https://doaj.org/article/5a70f718f1e1409096c9cf4d050ebc8c
Autor:
Nuria Pedreño-Lopez, Christine M. Dang, Brandon C. Rosen, Michael J. Ricciardi, Varian K. Bailey, Martin J. Gutman, Lucas Gonzalez-Nieto, Matthias G. Pauthner, Khoa Le, Ge Song, Raiees Andrabi, Kim L. Weisgrau, Nicholas Pomplun, José M. Martinez-Navio, Sebastian P. Fuchs, Jens Wrammert, Eva G. Rakasz, Jeffrey D. Lifson, Mauricio A. Martins, Dennis R. Burton, David I. Watkins, Diogo M. Magnani
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss , Pp 225-237 (2020)
Structural characterization of the HIV-1 Envelope (Env) glycoprotein has facilitated the development of Env probes to isolate HIV-specific monoclonal antibodies (mAbs). However, preclinical studies have largely evaluated these virus-specific mAbs aga
Externí odkaz:
https://doaj.org/article/583e2f5e1bdc4c94b11792ddc7103b3a
Autor:
Nuria Pedreño-Lopez, Brandon C. Rosen, Walter J. Flores, Matthew J. Gorman, Thomas B. Voigt, Michael J. Ricciardi, Kristin Crosno, Kim L. Weisgrau, Christopher L. Parks, Jeffrey D. Lifson, Galit Alter, Eva G. Rakasz, Diogo M. Magnani, Mauricio A. Martins, David I. Watkins
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The antiviral properties of broadly neutralizing antibodies against HIV are well-documented but no vaccine is currently able to elicit protective titers of these responses in primates. While current vaccine modalities can readily induce non-neutraliz
Externí odkaz:
https://doaj.org/article/953611f23bac4fb3b5b40dc083c6c0d6
Autor:
Brandon C. Rosen, Nuria Pedreño-Lopez, Michael J. Ricciardi, Jason S. Reed, Jonah B. Sacha, Eva G. Rakasz, David I. Watkins
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
CD8+ cytotoxic T lymphocytes (CTLs) exert potent antiviral activity after HIV/SIV infection. However, efforts to harness the antiviral efficacy of CTLs for HIV/SIV prophylaxis and therapy have been severely hindered by two major problems: viral escap
Externí odkaz:
https://doaj.org/article/134aa1a3a121485ab813ba24be22cd4c
Autor:
Lucas Gonzalez-Nieto, Isabelle M Castro, Georg F Bischof, Young C Shin, Michael J Ricciardi, Varian K Bailey, Christine M Dang, Nuria Pedreño-Lopez, Diogo M Magnani, Keisuke Ejima, David B Allison, Hwi Min Gil, David T Evans, Eva G Rakasz, Jeffrey D Lifson, Ronald C Desrosiers, Mauricio A Martins
Publikováno v:
PLoS Pathogens, Vol 15, Iss 9, p e1008015 (2019)
A prophylactic vaccine against human immunodeficiency virus (HIV) remains a top priority in biomedical research. Given the failure of conventional immunization protocols to confer robust protection against HIV, new and unconventional approaches may b
Externí odkaz:
https://doaj.org/article/7e6e831fadc24404a14cf0b3646c06d4
Autor:
Mauricio A Martins, Young C Shin, Lucas Gonzalez-Nieto, Aline Domingues, Martin J Gutman, Helen S Maxwell, Iris Castro, Diogo M Magnani, Michael Ricciardi, Nuria Pedreño-Lopez, Varian Bailey, Dillon Betancourt, John D Altman, Matthias Pauthner, Dennis R Burton, Benjamin von Bredow, David T Evans, Maoli Yuan, Christopher L Parks, Keisuke Ejima, David B Allison, Eva Rakasz, Glen N Barber, Saverio Capuano, Jeffrey D Lifson, Ronald C Desrosiers, David I Watkins
Publikováno v:
PLoS Pathogens, Vol 13, Iss 7, p e1006529 (2017)
The ability to control lentivirus replication may be determined, in part, by the extent to which individual viral proteins are targeted by the immune system. Consequently, defining the antigens that elicit the most protective immune responses may fac
Externí odkaz:
https://doaj.org/article/7f9298477dd24bad881bb9021f08cf80
Autor:
Jorge Carrillo, Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, Erola Ainsua-Enrich, Marco Brustolin, Maria Luisa Rodriguez de la Concepción, Nuria Pedreño-Lopez, Jordi Rodon, Victor Urrea, Edwards Pradenas, Silvia Marfil, Ester Ballana, Eva Riveira-Muñoz, Mónica Pérez, Núria Roca, Ferran Tarrés-Freixas, Guillermo Cantero, Anna Pons-Grífols, Carla Rovirosa, Carmen Aguilar-Gurrieri, Raquel Ortiz, Ana Barajas, Benjamin Trinité, Rosalba Lepore, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Nuria Izquierdo-Useros, Alfonso Valencia, Julià Blanco, Víctor Guallar, Bonaventura Clotet, Joaquim Segalés
Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been crucial to fight against the coronavirus disease 2019 pandemic. Most vaccines are based on a mutated version of the Spike glycoprotein [K986P/V987P (S-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08495551f88f367bb501e040fea01a7a
https://doi.org/10.21203/rs.3.rs-2846684/v1
https://doi.org/10.21203/rs.3.rs-2846684/v1